Grace Therapeutics (NASDAQ:GRCE) Receives “Buy” Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Grace Therapeutics (NASDAQ:GRCE – Free Report) in a report issued on Tuesday,Benzinga reports. HC Wainwright currently has a $12.00 price target on the stock. Grace Therapeutics Trading Down 0.9 % GRCE opened at $3.42 on Tuesday. The firm has a 50 day moving average of $3.68. […]
HC Wainwright reissued their buy rating on shares of Grace Therapeutics (NASDAQ:GRCE – Free Report) in a report issued on Tuesday,Benzinga reports. HC Wainwright currently has a $12.00 price target on the stock. Grace Therapeutics Trading Down 0.9 % GRCE opened at $3.42 on Tuesday. The firm has a 50 day moving average of $3.68. […]